|
|
Blood, 1 September 2006, Vol. 108, No. 5, pp. 1602-1610.
Prepublished online as a Blood First Edition Paper on May 2, 2006; DOI 10.1182/blood-2006-02-001016.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26
Holger K. Eltzschig,
Marion Faigle,
Simone Knapp,
Jorn Karhausen,
Juan Ibla,
Peter Rosenberger,
Kirsten C. Odegard,
Peter C. Laussen,
Linda F. Thompson, and
Sean P. Colgan
From the Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Tübingen, Germany; Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital, Boston, MA; and the Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and the Immunobiology and Cancer Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City.
Extracellular levels of adenosine increase during hypoxia. While acute increases in adenosine are important to counterbalance excessive inflammation or vascular leakage, chronically elevated adenosine levels may be toxic. Thus, we reasoned that clearance mechanisms might exist to offset deleterious influences of chronically elevated adenosine. Guided by microarray results revealing induction of endothelial adenosine deaminase (ADA) mRNA in hypoxia, we used in vitro and in vivo models of adenosine signaling, confirming induction of ADA protein and activity. Further studies in human endothelia revealed that ADA-complexing protein CD26 is coordinately induced by hypoxia, effectively localizing ADA activity at the endothelial cell surface. Moreover, ADA surface binding was effectively blocked with glycoprotein 120 (gp120) treatment, a protein known to specifically compete for ADA-CD26 binding. Functional studies of murine hypoxia revealed inhibition of ADA with deoxycoformycin (dCF) enhances protective responses mediated by adenosine (vascular leak and neutrophil accumulation). Analysis of plasma ADA activity in pediatric patients with chronic hypoxia undergoing cardiac surgery demonstrated a 4.1 ± 0.6-fold increase in plasma ADA activity compared with controls. Taken together, these results reveal induction of ADA as innate metabolic adaptation to chronically elevated adenosine levels during hypoxia. In contrast, during acute hypoxia associated with vascular leakage and excessive inflammation, ADA inhibition may serve as therapeutic strategy.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Ups and downs of adenosine
- Joel Linden
Blood 2006 108: 1430.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
J. C. Morote-Garcia, P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Blood,
June 15, 2008;
111(12):
5571 - 5580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Eckle, M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig
A2B adenosine receptor dampens hypoxia-induced vascular leak
Blood,
February 15, 2008;
111(4):
2024 - 2035.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Eckle, L. Fullbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. Ibla, P. Rosenberger, and H. K. Eltzschig
Identification of Ectonucleotidases CD39 and CD73 in Innate Protection during Acute Lung Injury
J. Immunol.,
June 15, 2007;
178(12):
8127 - 8137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Drucker
Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes: Preclinical biology and mechanisms of action
Diabetes Care,
June 1, 2007;
30(6):
1335 - 1343.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig
Physiological Roles of Vascular Nucleoside Transporters
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1004 - 1013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Eckle, T. Krahn, A. Grenz, D. Kohler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, et al.
Cardioprotection by Ecto-5'-Nucleotidase (CD73) and A2B Adenosine Receptors
Circulation,
March 27, 2007;
115(12):
1581 - 1590.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
